Healing Partnerships: How Pakistan's Medical, Surgical & Pharma Industries Can Transform African Healthcare

Healthcare is Africa's most urgent development challenge and, simultaneously, its greatest investment opportunity. With a continent of 1.4 billion people facing endemic disease burdens, rapidly growing urban populations with increasing non-communicable disease loads, and healthcare infrastructure often decades behind international standards, the demand for affordable, quality medical products, surgical instruments, and pharmaceutical drugs is staggering.

Pakistan, largely unknown in Africa as a healthcare partner, is in fact one of the world's most significant producers of surgical instruments — controlling over 30% of global surgical instrument production from the city of Sialkot — and has a pharmaceutical industry producing affordable, WHO-pre-qualified generic medicines that are directly relevant to Africa's healthcare needs. This session, with speakers Dr. Bari, Tauqeer-ul-Haq, and Saeed Shah, will make the case for Pakistan becoming a major healthcare supplier to Africa.

Sialkot: The World's Surgical Instrument Capital

The story of Sialkot's surgical instrument industry is one of the world's great industrial success stories. A single mid-sized Pakistani city produces approximately one-third of all surgical instruments sold globally — scissors, forceps, clamps, retractors, needle holders, and thousands of other specialised tools used in hospitals from Oslo to São Paulo. Sialkot's instrument makers have achieved CE marking (European conformity), FDA registration, and ISO 13485 medical device quality certification.

For African hospitals, clinics, and surgical centres, Sialkot's surgical instruments offer an extraordinary value proposition: world-class quality at price points 40-60% below European alternatives. Establishing direct procurement channels between African healthcare systems and Sialkot manufacturers — eliminating intermediaries — could save African health ministries hundreds of millions of dollars annually while upgrading surgical quality across the continent.

Pakistan's Pharmaceutical Industry: Affordable Generics for Africa

Pakistan's pharmaceutical sector produces a comprehensive range of generic medicines — antibiotics, antimalarials, antiretrovirals, cardiovascular drugs, diabetes medications, and vaccines — that are registered and approved by the Drug Regulatory Authority of Pakistan (DRAP) and, for an increasing range of products, by the WHO's prequalification programme.

• Antimalarial drugs produced in Pakistan at costs significantly below branded alternatives are relevant across SADC malaria-endemic regions
• Generic antiretrovirals (ARVs) for HIV treatment — a critical need across southern Africa — are produced by Pakistani pharma companies at competitive prices
• Vaccines and biologics manufactured in Pakistan can complement Africa's immunisation programmes
• Diabetes and cardiovascular medications, for Africa's growing burden of non-communicable diseases, represent a rapidly expanding market segment

Regulatory Pathways: Getting Pakistani Products into African Markets

One of the key practical challenges addressed in this session will be the regulatory pathway for Pakistani medical devices and pharmaceuticals in African markets. Different African nations have different regulatory requirements — some rely on WHO prequalification, others on equivalence with FDA or EMA approvals, others on their own national processes. Tauqeer-ul-Haq brings specific expertise in navigating these regulatory environments, and will outline the practical steps for Pakistani healthcare companies seeking market authorisation in SADC nations.

Hospital Equipment, Diagnostics & Medical Technology

Beyond instruments and drugs, Pakistan's medical sector produces hospital furniture, patient monitoring equipment, diagnostic consumables, and a growing range of medical technology products. As African nations invest in hospital infrastructure — driven by both public health imperatives and the growth of private healthcare — demand for these products will grow substantially. Pakistani manufacturers, offering internationally certified quality at competitive prices, are well-positioned to serve as preferred suppliers for African hospital procurement programmes.

Building Long-Term Healthcare Partnerships

The session will close by outlining a framework for long-term Pakistan-Africa healthcare partnerships — going beyond transactional product sales to explore areas like: joint venture pharmaceutical manufacturing in Africa using Pakistani technology, Pakistani hospital management companies operating in African cities, telemedicine partnerships connecting Pakistani medical specialists with African patients, and medical education programmes training African healthcare workers in Pakistan.

---